TC
ZYME icon

Truvestments Capital’s Zymeworks ZYME Stock Holding History

Truvestments Capital’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-231
Closed -$6.08K – 1222
2025
Q4 		$6.08K Hold
231
– – ﹤0.01% 768
2025
Q3 		$3.94K Sell
231
-78
-25% -$1.12K ﹤0.01% 862
2025
Q2 		$3.88K Hold
309
– – ﹤0.01% 767
2025
Q1 		$3.68K Sell
309
-125
-29% -$1.71K ﹤0.01% 787
2024
Q4 		$6.35K Buy
434
+175
+68% +$2.45K ﹤0.01% 667
2024
Q3 		$3.25K Buy
+259
New +$2.82K ﹤0.01% 737
2019
Q4 		– Sell
-1,000
Closed -$25K – 619
2019
Q3 		$25K Buy
1,000
+500
+100% +$12.5K 0.02% 379
2019
Q2 		$11K Hold
500
– – 0.01% 525
2019
Q1 		$8K Buy
+500
New +$7.75K 0.01% 548

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Truvestments Capital's ZYME Position: Q1 2026 in Review

Truvestments Capital sold out of Zymeworks (ZYME) in Q1 2026, closing a stake of 231 shares — an estimated $6.08K sold.

Truvestments Capital first reported a position in ZYME in Q1 2019 and held it in 9 quarters. The position peaked at $25K in Q3 2019. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Truvestments Capital reported no remaining Zymeworks position as of Q1 2026 after selling out during the quarter.
  • Truvestments Capital sold 231 Zymeworks shares in Q1 2026, an estimated $6.08K.
  • Truvestments Capital first reported a position in Zymeworks in Q1 2019 and held it in 9 quarters.
  • Truvestments Capital's Zymeworks position peaked at $25K in Q3 2019.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Truvestments Capital's 13F filing for Q1 2026, filed 13 May 2026.